Combination therapy using oral S-1 and targeted agents against human tumor xenografts in nude mice

In this study, combination therapies using the oral fluoropyrimidine tegafur-gimeracil-oteracil (S-1) with several targeted agents or antibodies, were evaluated. First, the effects of tyrosine kinase inhibitors (erlotinib hydrochloride, sorafenib tosilate and sunitinib malate) against human non-smal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: NUKATSUKA, MAMORU, SAITO, HITOSHI, NAKAGAWA, FUMIO, TSUJIMOTO, HIROAKI, SAKAMOTO, KAZUKI, TSUKIOKA, SAYAKA, UCHIDA, JUNJI, KINIWA, MAMORU, KOBUNAI, TAKASHI, TAKECHI, TEIJI
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2012
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3438730/
https://ncbi.nlm.nih.gov/pubmed/22969964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.484
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados